Access Bio Inc (950130) — Cash Flow Reinvestment Rate
Access Bio Inc (950130) has a Cash Flow Reinvestment Rate of 1548.52x as of March 2025, reinvesting ₩8.29 Billion (capex ₩635.11K plus investments ₩8.29 Billion) from operating cash flow of ₩5.35 Million. See Access Bio Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Access Bio Inc Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Access Bio Inc across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Access Bio Inc.
Annual Cash Flow Reinvestment Rate for Access Bio Inc (2012–2024)
Year-by-year capital reinvestment analysis for Access Bio Inc. See 950130 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1290.23x | ₩17.47 Billion | ₩13.54 Million | ₩1.40 Million | ▲ +895.2% |
| 2022 | 129.64x | ₩37.77 Billion | ₩291.33 Million | ₩14.90 Million | ▼ -48.9% |
| 2021 | 253.51x | ₩34.96 Billion | ₩137.90 Million | ₩28.76 Million | ▲ +85255.3% |
| 2020 | 0.30x | ₩10.91 Billion | ₩36.72 Billion | ₩10.38 Billion | ▼ -93.7% |
| 2016 | 4.74x | ₩10.03 Million | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩4.85 Billion | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩2.63 Billion | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.31 Billion | ₩1.85 Billion | ₩1.31 Billion | — |